Zevia PBC Class A ZVIA 深 滬
等待開盤 01-28 09:30:00 美东时间
2.095
+0.045
+2.20%
華盛通- 最 高2.1186
- 今 開2.06
- 成交量 73.52万股
- 最 低 2.00
- 昨 收 2.05
- 總市值 1.41亿
- 52周最高 3.70
- 市盈率 靜 --
- 換手率 1.09%
- 52周最低 1.655
- 委 比 3.63%
- 總股本 6738.92万
- 歷史最高 17.50
- 量 比 0.97
- 振 幅 5.79%
- 歷史最低 0.615
- 每 手 1
- 風險率 0.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zevia Posts On X "Our brand-new 30-pack Zevia Variety Pack is now available across all @Costco regions — our biggest Costco rollout yet!"
https://x.com/Zevia/status/2015848398944174196
01-27 02:25
Top 3 Risk Off Stocks That could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity...
01-15 19:59
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Telsey Advisory Group Maintains Outperform on Zevia, Maintains $6 Price Target
Telsey Advisory Group analyst Sarang Vora maintains Zevia (NYSE:ZVIA) with a Outperform and maintains $6 price target.
01-14 20:18
Zevia PBC Adds Experienced Consumer Marketer to Board
Zevia PBC ( ($ZVIA) ) has provided an announcement. On January 7, 2026, Zevia P...
01-08 06:16
Zevia Sees Q4 Sales $39.000M-$41.000M vs $40.214M Est
Zevia (NYSE:ZVIA) sees Q4 sales of $39.000 million-$41.000 million vs $40.214 million analyst estimate.
2025-11-06 05:18
Zevia Q3 EPS $(0.04), Inline, Sales $40.800M Beat $39.330M Estimate
Zevia (NYSE:ZVIA) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $40.800 million which
2025-11-06 05:13
Zevia Posts On X "Big news for our Canadian friends! Our refreshingly simple soda is now on shelves at @WalmartCanada. Stock up on classic zero fake, zero-sugar Zevia flavors like Cream Root Beer, Cola, Ginger Ale and more today!"
https://x.com/Zevia/status/1986119837635264847
2025-11-06 01:19
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
2025-10-30 14:22
Telsey Advisory Group Maintains Outperform on Zevia, Maintains $6 Price Target
Telsey Advisory Group analyst Sarang Vora maintains Zevia (NYSE:ZVIA) with a Outperform and maintains $6 price target.
2025-10-29 18:55
